SENS Research Foundation – The SENSible Blog

SENS Research Foundation – The SENSible Blog

Publication
0 followers

Independent nonprofit blog on translational biotech/aging research and development.

Becoming Well-Fed and Sedentary Accelerates Penguin Aging
NewsApr 1, 2026

Becoming Well-Fed and Sedentary Accelerates Penguin Aging

A new Nature Communications study shows that king penguins moved from the wild to zoo environments—mirroring a sedentary, well‑fed Western lifestyle—experience epigenetic age acceleration of roughly 2.5 to 6.5 years. Researchers used a penguin‑specific methylation clock and identified nearly 300...

By SENS Research Foundation – The SENSible Blog
Cellular Senescence and Senotherapeutics: The Expert Roundup
NewsMar 26, 2026

Cellular Senescence and Senotherapeutics: The Expert Roundup

Cellular senescence has become a focal point for longevity medicine, prompting a surge of senolytic and senomorphic drug development. Pioneering studies showed that clearing senescent cells can extend healthspan, leading biotech firms like Rubedo, SENISCA, Deciduous Therapeutics, and Arda Therapeutics...

By SENS Research Foundation – The SENSible Blog
Two Polyunsaturated Lipids Demonstrate Senolytic Activity
NewsMar 25, 2026

Two Polyunsaturated Lipids Demonstrate Senolytic Activity

Researchers identified two conjugated polyunsaturated fatty acids, α‑eleostearic acid (α‑ESA) and its methyl ester (α‑ESA‑me), as potent senolytics that selectively eliminate senescent cells. In mouse models, short‑term dosing reduced senescence markers and SASP factors across liver, heart, kidney, and lung...

By SENS Research Foundation – The SENSible Blog
BioAge Labs Provides Business Updates
NewsMar 24, 2026

BioAge Labs Provides Business Updates

BioAge Labs reported full‑year 2025 results, highlighting positive Phase 1 data for its oral NLRP3 inhibitor BGE‑102, which achieved up to 86% reduction in hsCRP and strong suppression of IL‑1β, IL‑6, and fibrinogen. The company announced a Phase 2a cardiovascular risk trial...

By SENS Research Foundation – The SENSible Blog
Meat Consumption May Benefit APOE4 Carriers
NewsMar 20, 2026

Meat Consumption May Benefit APOE4 Carriers

A Swedish cohort study of 2,100 older adults found that high consumption of total and unprocessed meat was linked to slower cognitive decline and a 55% lower dementia risk among APOE ε4 carriers, while non‑carriers saw no benefit. The protective...

By SENS Research Foundation – The SENSible Blog
How Zinc Protects Injured Arteries From Accelerated Aging
NewsMar 16, 2026

How Zinc Protects Injured Arteries From Accelerated Aging

Researchers published in Aging Cell report that vascular injury induces misshapen nuclei in smooth muscle cells, accelerating cellular senescence. Human femoral arteries post‑angioplasty and rat carotid injury models both displayed nuclear dysmorphism linked to prelamin A buildup. The study identifies...

By SENS Research Foundation – The SENSible Blog
Scientists Successfully Freeze and Rewarm Mouse Brain Slices
NewsMar 10, 2026

Scientists Successfully Freeze and Rewarm Mouse Brain Slices

Researchers at Friedrich‑Alexander‑Universität Erlangen‑Nürnberg successfully vitrified mouse brain slices and, in a limited trial, an entire mouse brain, preserving neuronal structure and function after rewarming. By using a high‑concentration cryoprotective agent cocktail, they avoided ice crystal formation, maintained synaptic architecture,...

By SENS Research Foundation – The SENSible Blog
Novel Mechanism for Parkinson’s Is Linked to ATP Deficiency
NewsMar 3, 2026

Novel Mechanism for Parkinson’s Is Linked to ATP Deficiency

Scientists at Ludwig Maximilian University discovered that loss of the DJ-1 protein triggers ATP deficiency in human dopaminergic neurons, leading to reduced VMAT2 levels and impaired dopamine vesicle loading. The resulting dopamine oxidation fuels accumulation of pathological α‑synuclein species, a...

By SENS Research Foundation – The SENSible Blog
Cellular Reprogramming: The Expert Roundup
NewsFeb 27, 2026

Cellular Reprogramming: The Expert Roundup

A round‑up of leading experts highlights how cellular reprogramming has moved from a laboratory curiosity to a near‑clinical anti‑aging platform. Researchers describe partial, epigenetic‑focused approaches that can rejuvenate cells without erasing identity, and four biotech firms outline their distinct delivery...

By SENS Research Foundation – The SENSible Blog
Menopausal Hormone Therapy Does Not Increase Mortality
NewsFeb 25, 2026

Menopausal Hormone Therapy Does Not Increase Mortality

A Danish register study of over 800,000 women examined the long‑term safety of menopausal hormone therapy (MHT). About 12% of participants used MHT for a median of 1.7 years, and the analysis found no association between MHT use and all‑cause...

By SENS Research Foundation – The SENSible Blog
Thermogeneration by White Fat Could Be Used to Treat Obesity
NewsFeb 24, 2026

Thermogeneration by White Fat Could Be Used to Treat Obesity

Researchers at Cornell uncovered a previously unknown thermogenic pathway in white adipocytes, where free fatty acids induce proton leakage through the mitochondrial ADP/ATP carrier (AAC). This AAC‑mediated uncoupling mirrors brown‑fat heat production without involving UCP1. In mouse models, enhancing intracellular...

By SENS Research Foundation – The SENSible Blog
How a Sirtuin Protects Against Brain Diseases
NewsFeb 23, 2026

How a Sirtuin Protects Against Brain Diseases

Researchers in Aging Cell reveal that the nuclear sirtuin SIRT6 safeguards brain health by preserving nucleolar integrity and curbing excess protein synthesis. Loss of SIRT6 triggers nucleolar enlargement, heightened rRNA production, and uncontrolled protein translation, leading to protein aggregation and...

By SENS Research Foundation – The SENSible Blog
AI Tool Sets New Standard in Diagnosing Rare Diseases
NewsFeb 20, 2026

AI Tool Sets New Standard in Diagnosing Rare Diseases

A new multi‑agent system called DeepRare, built on the DeepSeek‑V3 large language model and over 40 specialized tools, outperformed 15 competing AI models and human physicians in diagnosing rare diseases. Across 6,401 cases covering 2,919 rare conditions, it achieved a...

By SENS Research Foundation – The SENSible Blog
A Circulating Inflammation Suppressor Decreases Mortality
NewsFeb 19, 2026

A Circulating Inflammation Suppressor Decreases Mortality

Researchers used Mendelian randomization to demonstrate that the inflammatory cytokine IL6 directly increases all‑cause mortality, while its soluble receptor IL6R has the opposite effect. Elevated circulating IL6R was linked to lower risk of lung cancer, diabetes, stroke and coronary artery...

By SENS Research Foundation – The SENSible Blog